ValorQ4, 24Q4, 25TTMFlujo de caja de las actividades de inversión———Flujo de caja de las actividades financieras———Flujo de caja libre———
Molecular Partners AG - American Depositary Shares
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development.